Stay updated on Pediatric Cabozantinib Clinical Trial
Sign up to get notified when there's something new on the Pediatric Cabozantinib Clinical Trial page.

Latest updates to the Pediatric Cabozantinib Clinical Trial page
- Check2 days agoChange DetectedThe study record’s update dates changed from August 27–28, 2026, to November 10–13, 2026.SummaryDifference0.1%

- Check9 days agoChange DetectedThe clinical trial page now displays the study record for cabozantinib in young patients with sarcomas, Wilms tumor, and other rare tumors, including its design, eligibility criteria, outcomes, and study locations.SummaryDifference100%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to related updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov page displaying a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Pediatric Cabozantinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Cabozantinib Clinical Trial page.